Nipro Corp
TSE:8086

Watchlist Manager
Nipro Corp Logo
Nipro Corp
TSE:8086
Watchlist
Price: 1 407.5 JPY -0.32% Market Closed
Market Cap: ¥229.6B

Operating Margin

4.4%
Current
Improving
by 0.5%
vs 3-y average of 3.9%

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
4.4%
=
Operating Income
¥28.5B
/
Revenue
¥650B

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
4.4%
=
Operating Income
¥28.5B
/
Revenue
¥650B

Peer Comparison

Country Company Market Cap Operating
Margin
JP
Nipro Corp
TSE:8086
229.6B JPY
Loading...
JP
Hoya Corp
TSE:7741
8.7T JPY
Loading...
CH
Alcon AG
SIX:ALC
30.9B CHF
Loading...
US
Medline Inc
NASDAQ:MDLN
35.4B USD
Loading...
DK
Coloplast A/S
CSE:COLO B
121.3B DKK
Loading...
US
Align Technology Inc
NASDAQ:ALGN
11.6B USD
Loading...
UK
ConvaTec Group PLC
LSE:CTEC
4.7B GBP
Loading...
KR
HLB Inc
KOSDAQ:028300
8.8T KRW
Loading...
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
42.8B CNY
Loading...
CA
Bausch + Lomb Corp
NYSE:BLCO
5.9B USD
Loading...
CH
Ypsomed Holding AG
SIX:YPSN
4.2B CHF
Loading...

Market Distribution

In line with most companies in Japan
Percentile
32st
Based on 6 730 companies
32st percentile
4.4%
Low
-125 500% — 4.2%
Typical Range
4.2% — 10.6%
High
10.6% — 9 743.7%
Distribution Statistics
Japan
Min -125 500%
30th Percentile 4.2%
Median 7%
70th Percentile 10.6%
Max 9 743.7%

Nipro Corp
Glance View

Market Cap
229.6B JPY
Industry
Health Care

Nipro Corporation, a prominent player in the medical industry, began as a humble glass-tubing business in the heart of Japan in 1954. Over the decades, it metamorphosed into a sprawling conglomerate with a nuanced focus on healthcare. Today, Nipro is intricately woven into the fabric of the medical supply chain. Its products range from dialysis equipment to diabetes care and even medical glass products, evidencing a broad spectrum of specialties. This diversification is not simply an expansion but a strategic integration that enables the company to leverage its expertise across related domains, ensuring resilience in the ever-evolving healthcare market. The engine powering Nipro’s business model lies in its vertical integration and global footprint. By manufacturing an array of products internally, from raw materials like glass and plastics to final medical devices, Nipro maintains stringent quality control and cost efficiencies. Beyond Japan, the company has established a significant presence in over 50 countries, tapping into diverse markets with its extensive portfolio. Strategic partnerships and mergers further bolster its global expansiveness, enhancing its distribution networks. The seamless intersection of innovation, quality, and market reach solidifies Nipro's stature as a leading entity in healthcare solutions, driving its sustained financial performance.

Intrinsic Value
2 190.69 JPY
Undervaluation 36%
Intrinsic Value
Price
What is Operating Margin?
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
How is Operating Margin calculated?

Operating Margin is calculated by dividing the Operating Income by the Revenue.

Operating Margin
4.4%
=
Operating Income
¥28.5B
/
Revenue
¥650B
What is Nipro Corp's current Operating Margin?

The current Operating Margin for Nipro Corp is 4.4%, which is above its 3-year median of 3.9%.

How has Operating Margin changed over time?

Over the last 3 years, Nipro Corp’s Operating Margin has increased from 3.4% to 4.4%. During this period, it reached a low of 3.3% on Mar 31, 2023 and a high of 4.7% on Dec 31, 2023.

Back to Top